Gilead Sciences

Gilead Sciences (NASDAQ: GILD) is an American biotechnology company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The company has fourteen commercially available prod... More

Business

Number of employees:

number date
  • 2,515
  • 2007

Venture Investors:

Revenue:

Currency Amount Valid Date
  • 5,335,750,000
  • Dec 31, 2008
  • 3,026,100,000
  • Dec 31, 2006
View entire collection »

Operating Income:

Currency Amount Valid Date
  • 2,678,540,000
  • Dec 31, 2008
  • 1,682,600,000
  • Dec 31, 2006
View entire collection »

Net profit:

Currency Amount Valid Date
  • 2,011,150,000
  • Dec 31, 2008

Cash:

Currency Amount Valid Date
  • 1,459,300,000
  • Dec 31, 2008

Current Assets:

Currency Amount Valid Date
  • 4,300,280,000
  • Dec 31, 2008

Total Assets:

Currency Amount Valid Date
  • 7,018,570,000
  • Dec 31, 2008

Current Liabilities:

Currency Amount Valid Date
  • 1,220,990,000
  • Dec 31, 2008

Total Liabilities:

Currency Amount Valid Date
  • 2,866,090,000
  • Dec 31, 2008

Retained Earnings:

Currency Amount Valid Date
  • 382,870,000
  • Dec 31, 2008
top ↑

Ranked item

Appears in ranked lists:

List Rank Year
  • 444
  • 2009
  • 536
  • 2008
  • 801
  • 2006
View entire collection »

Fortune 1000 of 2009

top ↑ top ↑ top ↑

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!